Introduction & Objective: We previously suggested that the regions of intra-islet ductal cells (IIDCs) play roles as the source for endocrine cells, particularly for α-cells, in C414A-CRY1 transgenic mice (TG) (ADA 2023), the characters of IIDCs relevant to the α-cell neogenesis are yet unknown. To clarify the points, we conducted experiments in terms of reactivity to DBA-lectin as well as of the expression of TFF2.

Methods: The cells constituting developed IIDC (of duct periphery longer than 500 µm) in TG were classified as strongly or weakly positive both for anti-TFF2 antibodies and for DBA-lectin. The positional correlation among glucagon-producing cells present in IIDC compartments and the classified IIDC were examined.

Results: Immature IIDCs embedded inside islets were homogeneous for DBA-lectin-reactivity as reported previously: DBA-lectin-weakly positive (ADA 2019). By contrast, it was newly uncovered that developed IIDCs showed variations in phenotypes for the reactivities to DBA-lectin. Heterogeneity in TFF2 expression was also observed in developed IIDCs. Glucagon-producing cells were more frequently located near DBA-lectin-weakly positive IIDCs (~54% higher than near DBA-lectin-strongly positive ones; P<0.01, t-test). While glucagon-producing cells were more frequently located near TFF2-strongly expressing IIDCs (~42% higher than near TFF2-weakly expressing ones; P<0.001, t-test). Furthermore, DBA-lectin-strongly positive IIDCs tended to be TFF2-weakly expressing ones.

Conclusion: Our results suggest that TFF2 in IIDCs promotes α-cell neogenesis and/or plays some important roles in the maintenance of newborn α-cells. DBA-lectin-strongly positive characteristics of IIDCs possibly suppress TFF2 expression, thereby acting inhibitory manner for α-cell neogenesis in such IIDCs.

Disclosure

S. Okano: None. S. Kanno: None. Y. Sasaki: None. M. Igarashi: None. O. Nakajima: None.

Funding

Grants-in-Aid for Scientific Research (19K07498); Tohoku University Institute of Development, Aging and Cancer.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.